Work Here?
Quanterix focuses on ultra-sensitive biomarker detection for early disease detection and monitoring in biotechnology and healthcare. Their main technology, Simoa (Single Molecule Array), allows for the identification of biomarkers at very low levels, which is crucial for detecting diseases before symptoms appear. Quanterix differentiates itself by enhancing the sensitivity and specificity of biomarker detection, providing valuable tools for pharmaceutical companies and clinical laboratories. The company's goal is to empower early disease detection and improve patient outcomes.
Company Stage
IPO
Employees
201-500
Industries
Biotechnology, Healthcare
Total Funding
$118.7M
Headquarters
Lexington, Kentucky
Founded
2007
Help us improve and share your feedback! Did you find this helpful?
Find jobs on Simplify and start your career today